Infections with biological therapy: strategies for risk minimization in tropical and developing countries

被引：4

作者：

Perez-Diaz, Carlos E. ^{[1
,2
,3
]}

Uribe-Pardo, Erika ^{[1
]}

Calixto, Omar-Javier ^{[1
]}

Faccini-Martinez, Alvaro A. ^{[4
]}

Rodriguez-Morales, Alfonso J. ^{[5
,6
]}

机构：

[1] SAI, Bogota, Colombia

[2] Clin Marly, Dept Infect Dis, Bogota, Colombia

[3] Hosp Samaritana, Dept Infect Dis, Bogota, Colombia

[4] Univ Fed Espirito Santo, Ctr Ciencias, Programa Posgrad Doencas Infecciosas, Vitoria, ES, Spain

[5] Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira 660001, Risaralda, Colombia

[6] OLFIS, Bucaramanga, Santander, Colombia

来源：

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2016年 / 10卷 / 12期

关键词：

autoimmune disease; rheumatoid arthritis; tuberculosis; biological therapy; infectious diseases; CHRONIC CHAGAS-DISEASE; HEPATITIS-B-VIRUS; RHEUMATOID-ARTHRITIS; ANKYLOSING-SPONDYLITIS; LATIN-AMERICA; IMMUNOCOMPROMISED PATIENTS; ALPHA ANTAGONISTS; HEALTH-CARE; FOLLOW-UP; IMMUNOSUPPRESSION;

D O I：

10.3855/jidc.8222

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

In recent decades, biological therapy has enabled disease activity control and improved quality of life in patients with autoimmune diseases. These therapies that are involved in immune response modifications and change multiple immunological pathways induce an incremental risk for certain infectious diseases. Though there have been recent advances in risk assessment for biological therapy, there is a lack of data and recommendati ons for assessing risks in populations with high prevalence of infectious diseases, such as those located in tropical areas and developing countries. We performed a review on infections with biological therapy as well strategies for risk minimization in areas with a high prevalence of tropical diseases.

引用

页码：1278 / 1285

页数：8

共 50 条

[1] Opportunistic Infections in Biological Therapy, Risk and Prevention
Bryant, Paul A.
Baddley, John W.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2017, 43 (01) : 27 - +
[2] Posttransplant infections in the tropical countries
Jha, V
Chugh, KS
ARTIFICIAL ORGANS, 2002, 26 (09) : 770 - 777
[3] Role of biological therapy for inflammatory bowel disease in developing countries
Rogler, Gerhard
Bernstein, Charles N.
Sood, Ajit
Goh, Khean Lee
Yamamoto-Furusho, Jesus K.
Abbas, Zaigham
Fried, Michael
GUT, 2012, 61 (05) : 706 - 712
[4] Role of biological therapy for inflammatory bowel disease in developing countries
Arebi, Naila
GUT, 2013, 62 (02) : 334 - 334
[5] Risk management strategies for HIV in blood transfusion in developing countries
Bharucha, ZS
VOX SANGUINIS, 2002, 83 : 167 - 171
[6] Strategies for risk assessment and control in welding: Challenges for developing countries
Hewitt, PJ
ANNALS OF OCCUPATIONAL HYGIENE, 2001, 45 (04): : 295 - 298
[7] Antibiotic strategies for developing countries: Experience with acute respiratory tract infections in Pakistan
Qazi, SA
CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) : 214 - 218
[8] Skin infections in developing countries
Afsar, Fatma Sule
CURRENT OPINION IN PEDIATRICS, 2010, 22 (04) : 459 - 466
[9] HEPATITIS INFECTIONS UPON SOJOURN IN TROPICAL AND SUB-TROPICAL DEVELOPING COUNTRIES AND THEIR DETERMINATION BY ACCIDENT INSURANCE UNDERWRITER
DIESFELD, HJ
MEDIZINISCHE KLINIK, 1974, 69 (40) : 1634 - 1638
[10] Neonatal infections in developing countries
Bhutta, ZA
PERINATAL MEDICINE OF THE NEW MILLENNIUM, 2001, : 407 - 415

← 1 2 3 4 5 →